Literature DB >> 19285759

Berbamine derivatives: a novel class of compounds for anti-leukemia activity.

Jinwen Xie1, Ting Ma, Ying Gu, Xuzhao Zhang, Xi Qiu, Lei Zhang, Rongzhen Xu, Yongping Yu.   

Abstract

Our previous studies showed that the natural compound berbamine, from Chinese herb Berberis amurensis, selectively induces apoptosis of imatinib (IM)-resistant-Bcr/Abl-expressing leukemia cells from the K562 cell line and CML patients. Here, a series of new berbamine derivatives were obtained by synthesis. In this series, high to very high activity in vitro has been found. Compounds 2e, 2g, 3f, 3k, 3q and 3u exhibited consistent high anti-tumor activity for imatinib-resistant K562 leukemia cells. Their IC(50) values at 48h were 0.36-0.55 microM, whereas berbamine IC(50) value was 8.9 microM. Cell cycle analysis results showed that compound 3h could reduce G0/G1 cells. In particular, these compounds displayed potent inhibition of the cytoplasm-to-nucleus translocation of NF-kappaB p65 which plays a critical role in the survival of leukemia stem cells. These results suggest that berbamine could be a good starting point for the development of novel lead compounds in the fight against leukemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19285759     DOI: 10.1016/j.ejmech.2009.02.018

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  11 in total

1.  Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell Lymphoma.

Authors:  Ying Gu; Jiawei Zhang; Xiaoxiao Ma; Byung-Wook Kim; Hailong Wang; Jinfan Li; Yi Pan; Yang Xu; Lili Ding; Lu Yang; Chao Guo; Xiwei Wu; Jun Wu; Kirk Wu; Xiaoxian Gan; Gang Li; Ling Li; Stephen J Forman; Wing-Chung Chan; Rongzhen Xu; Wendong Huang
Journal:  Cancer Cell       Date:  2017-07-10       Impact factor: 31.743

2.  Aberrant activation of CaMKIIγ accelerates chronic myeloid leukemia blast crisis.

Authors:  Y Gu; W Zheng; J Zhang; X Gan; X Ma; Z Meng; T Chen; X Lu; Z Wu; W Huang; R Xu
Journal:  Leukemia       Date:  2016-03-08       Impact factor: 11.528

3.  Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells.

Authors:  Sangkil Nam; Jun Xie; Angela Perkins; Yuelong Ma; Fan Yang; Jun Wu; Yan Wang; Rong-Zhen Xu; Wendong Huang; David A Horne; Richard Jove
Journal:  Mol Oncol       Date:  2012-06-02       Impact factor: 6.603

4.  CaMKII γ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine.

Authors:  Ying Gu; Ting Chen; Zhipeng Meng; Yichao Gan; Xiaohua Xu; Guiyu Lou; Hongzhi Li; Xiaoxian Gan; Hong Zhou; Jinfen Tang; Genbo Xu; Liansheng Huang; Xiaohong Zhang; Yongming Fang; Kai Wang; Shu Zheng; Wendong Huang; Rongzhen Xu
Journal:  Blood       Date:  2012-10-16       Impact factor: 22.113

5.  Berbamine induces SMMC-7721 cell apoptosis via upregulating p53, downregulating survivin expression and activating mitochondria signaling pathway.

Authors:  Ying Cao; Jianbo Cao; Binbin Yu; Shusheng Wang; Lili Liu; Li Tao; Wanping Sun
Journal:  Exp Ther Med       Date:  2017-12-15       Impact factor: 2.447

6.  2-methylbenzoyl berbamine, a multi-targeted inhibitor, suppresses the growth of human osteosarcoma through disabling NF-κB, ERK and AKT signaling networks.

Authors:  Weixu Li; Yan Li; Wenjia Tian; Xiuguo Han; Jie Zhao; Zengfeng Xin; Hejia Hu; Jun Li; Kai Hang; Rongzhen Xu
Journal:  Aging (Albany NY)       Date:  2020-07-26       Impact factor: 5.682

7.  CAMK2G is identified as a novel therapeutic target for myelofibrosis.

Authors:  Masashi Miyauchi; Ken Sasaki; Yuki Kagoya; Kazuki Taoka; Yosuke Masamoto; Sho Yamazaki; Shunya Arai; Hideaki Mizuno; Mineo Kurokawa
Journal:  Blood Adv       Date:  2022-03-08

8.  Targeting MYC and BCL2 by a natural compound for "double-hit" lymphoma.

Authors:  Xiaoqian Liu; Senlin Xu; Jiawei Zhang; Mingjie Fan; Jun Xie; Bingfeng Zhang; Hongzhi Li; Guohua Yu; Yinghui Liu; Yuanfeng Zhang; Joo Song; David Horne; Wing C Chan; Xiaoxia Chu; Wendong Huang
Journal:  Hematol Oncol       Date:  2022-05-05       Impact factor: 4.850

Review 9.  Medicinal Plants with Anti-Leukemic Effects: A Review.

Authors:  Tahani Maher; Raha Ahmad Raus; Djabir Daddiouaissa; Farah Ahmad; Noor Suhana Adzhar; Elda Surhaida Latif; Ferid Abdulhafiz; Arifullah Mohammed
Journal:  Molecules       Date:  2021-05-07       Impact factor: 4.411

Review 10.  Berberis Plants-Drifting from Farm to Food Applications, Phytotherapy, and Phytopharmacology.

Authors:  Bahare Salehi; Zeliha Selamoglu; Bilge Sener; Mehtap Kilic; Arun Kumar Jugran; Nunziatina de Tommasi; Chiara Sinisgalli; Luigi Milella; Jovana Rajkovic; Maria Flaviana B Morais-Braga; Camila F Bezerra; Janaína E Rocha; Henrique D M Coutinho; Adedayo Oluwaseun Ademiluyi; Zabta Khan Shinwari; Sohail Ahmad Jan; Ebru Erol; Zulfiqar Ali; Elise Adrian Ostrander; Javad Sharifi-Rad; María de la Luz Cádiz-Gurrea; Yasaman Taheri; Miquel Martorell; Antonio Segura-Carretero; William C Cho
Journal:  Foods       Date:  2019-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.